Barbell Medicine Podcast

Episode #388: Muscle Imbalances, Red Meat Risk, and the Science of Body Fat Set Points

In this special preview of the Barbell Medicine Plus Direct Line, Dr. Jordan Feigenbaum and Dr. Austin Baraki move past the fitness basics to tackle high-level technical nuances. We dive into the persistent myth of "muscle imbalances" and why your asymmetry might actually be a functional feature of your training.We also address the "meat" of the cardiovascular debate: is red meat and saturated fat consumption still risky if you are highly active and have a high-fiber diet? Finally, we explore the Dual Intervention Point Model to explain why the body defends its energy stores and how our environment has shifted the biological "set point" for body fat.Timestamps00:00 – Barbell Medicine Plus: Special Annual Membership Promotion01:03 – Muscle Imbalances: A Reliable Predictor of Pain?03:59 – Acuted vs. Gradually Acquired Asymmetries08:55 – How Coaches Should Manage "Alignment" Beliefs11:54 – Is Red Meat Necessary to Limit if You Are Otherwise Healthy?15:36 – The Role of Substitution: Plant vs. Animal Protein19:50 – Analyzing the Lean Mass Hyper-Responder (LMHR) Phenotype26:20 – The Dual Intervention Point Model of Body Fatness30:26 – Lipostat, Gravistat, and the Regulation of Energy StoresNext StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/ Key TakeawaysAsymmetry as a Feature: Human bodies are not naturally symmetrical. In many athletes—such as tennis players, pitchers, or rowers—asymmetry is a functional adaptation to the sport's demands.The Pathological vs. The Normal: Acutely acquired asymmetries (post-surgery or trauma) require specific clinical attention. Long-standing or gradually acquired asymmetries are rarely the primary driver of pain.Saturated Fat & The Healthy User Bias: While fit individuals have a lower overall risk profile, elevated LDL and ApoB particles represent a "time-volume" exposure risk that should not be ignored based solely on lifestyle.The Lean Mass Hyper-Responder (LMHR): We analyze the bold claims surrounding the LMHR phenotype and discuss why mechanistic hypothesizing currently lacks the "hard human outcome receipts" to prove long-term safety.Body Fat Regulation: The Dual Intervention Point Model suggests the body defends a lower boundary (starvation) and an upper boundary (predation). In the modern environment, the "predation pressure" has vanished, leading to a genetic drift upward in body fat set points.Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #387: The Valsalva Maneuver- Blood Pressure & Safety in Lifting

Most doctors, trainers, and "safety-first" influencers warn that holding your breath while lifting is a dangerous habit that could lead to a stroke or heart failure. By looking back at the 300-year history of the Valsalva maneuver—from a 1704 ear treatment to the "boogeyman" blood pressure studies of the 1980s—we dismantle the myth of the "fragile tube." Discover the science of the "pressurized suit" and why your body is actually designed to handle extreme internal pressure during heavy exertion.Key TakeawaysThe 'Ear Trick' Origins: Originally described in 1704 by Antonio Maria Valsalva as a way to clear middle-ear infections, the maneuver wasn't linked to cardiovascular risk until the 1850s "Weber experiments."The MacDougall 480/350 Study: Why the finding of massive blood pressure spikes during leg presses may have created a "villain arc" for the Valsalva maneuver in modern medicine.Transmural Pressure Protection: A blood vessel fails when internal pressure significantly exceeds external support; during a Valsalva, the internal spike is matched by an external "cradle" of intra-thoracic and cerebrospinal fluid pressure.Reflexive vs. Intentional Bracing: The Valsalva maneuver is a hard-wired reflex that triggers involuntarily at approximately 80% of a maximal voluntary contraction to stabilize the trunk.Vascular Safety and Stroke Risk: Evidence suggests that for healthy populations, the risk of a vascular "pop" is negligible because the pressure gradient across the vessel wall (transmural pressure) remains stable.Pregnancy and Fetal Safety: Clinical data on pregnant athletes shows that heavy, braced lifting up to 90% of a 10-rep max does not cause fetal distress or compromised uterine blood flow.The 'Hissing' Safety Valve: For those prone to lightheadedness or pelvic floor symptoms, using a slow, active exhalation (a hiss) during the concentric phase can help manage pressure transitions.Timestamps[00:00] History: From the 1704 Ear Treatise to the Weber Fainting Experiments[05:26] The 1985 MacDougall Study: Origin of the "480/350" Blood Pressure Boogeyman[06:22] The Anatomy of a Breath-Hold: The 4 Phases of the Valsalva Maneuver[12:59] Reflexive Bracing: Why You Can’t Stop Yourself from Holding Your Breath[28:24] The Pressurized Suit: Transmural Pressure and Vascular Safety[31:00] The Brain and the Box: CSF Protection and Intracranial Pressure[35:27] Heart Health: Does Lifting Cause Pathological Heart Thickening?[41:17] Special Populations: Strokes, Aneurysms, and the 'Pop' Theory[46:15] The Pelvic Floor: Stress Incontinence and the Weightlifter's Paradox[49:34] Pregnancy: Monitoring Fetal Heart Rates During Heavy Braced Lifting[56:42] Contraindications: When is the Valsalva Maneuver Actually Dangerous?Next StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Barbell Medicine Vital 5 Action Plan: https://www.barbellmedicine.com/vital-5-action-plan/ ReferencesMiddle Cerebral Artery and ValsalvaValsalva During Resistance TrainingValsalva and Force Production and WeightIAP During CoughingLifting Belt’s Effects Leg PressTraining and Heart AdaptationsPowerlifter’s HeartsValsalva Maneuver and Cerebrovascular DynamicsRT, VM, and Cerebrovascular PressuresWomen’s Pelvic FloorsPregnancy and RT and AgainFetal Heart RateInjury RiskHerniaSUI PodcastOur Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #386: Longevity Myths- Biological Clocks, GLP-1 Muscle Loss, and What Actually Predicts Lifespan

The longevity industry is now worth over $100 billion per year. From DNA methylation clocks to multi-cancer blood tests and GLP-1 medications, the promises are bold.But what actually predicts lifespan?In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the science behind biological clocks, the real story on GLP-1–related muscle loss, and introduce the Barbell Medicine “Vital Five” — a clinically grounded framework for health and longevity.Key Points:The Three Generations of Biological Clocks: Understanding the evolution of DNA methylation tests from simple chronological markers (Horvath) to sophisticated predictors of mortality (GrimAge) and functional decline (DunedinPACE).Descriptive vs. Prescriptive Metrics: Why a biological age score acts as a lagging indicator rather than a tool for clinical decision-making, compared to traditional risk factors like blood pressure and ApoB.GLP-1s and Sarcopenia Reality: A nuanced look at lean mass loss during semaglutide and tirzepatide treatment, emphasizing the difference between total lean mass and actual skeletal muscle quality.Weight-Independent Benefits of Incretins: Analyzing data from the SELECT and FLOW trials regarding the direct cardioprotective and renal benefits of GLP-1 receptor agonists.The Limitations of Early Detection: Why multi-cancer early detection (MCED) tests can lead to diagnostic loops and how clinical utility differs from marketing promises.The Barbell Medicine Vital Five: A definitive framework for longevity focusing on blood pressure, ApoB, VO2 max, relative strength, and body composition.Neurodegenerative Research Outlook: A critical review of the EVOKE trials and the potential (or lack thereof) for current weight-loss medications in treating established Alzheimer's disease.Next StepsFor evidence-based resistance training programs: barbellmedicine.com/training-programsFor individualized training consultation: barbellmedicine.com/coachingExplore our full library of articles on health and performance: barbellmedicine.com/resourcesTo join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com Timestamps:00:00 – The $100 Billion Longevity IndustryThe explosion of biological age testing, cancer screening startups, and anti-aging marketing.01:45 – The “Eyeball Test”: Physician Intuition vs Biological Age ScoresDoes looking “older” or “younger” actually mean anything clinically?Biological Clocks04:33 – What Is DNA Methylation? Epigenetic “Post-It Notes”How biological clocks are built.07:28 – The Three Generations of Biological ClocksHorvath → GrimAge → DunedinPACE.12:01 – Why Biological Age Is a Lagging IndicatorWhy blood pressure and ApoB still explain most of the variance.16:30 – Should You Buy a Biological Age Test?Clinical utility vs curiosity.Multi-Cancer Early Detection Tests17:10 – The Promise of Multi-Cancer Early Detection TestsThe appeal of a single blood draw.23:20 – The Pathfinder Study: Sensitivity, Specificity, and False PositivesWhy early-stage detection remains limited.28:30 – Lead-Time Bias and OverdiagnosisFinding cancer earlier vs actually improving survival.29:30 – Who (If Anyone) Should Consider MCED Testing?31:00 – Why Exercise Guidelines May Be IncompleteFrom “just move” to measurable targets.38:00 – VO2 Max: The Strongest Predictor of Survival?Elite cardiorespiratory fitness and mortality risk.40:20 – Strength vs Power: Which Matters More?Why muscular power may be underestimated.43:45 – Comparing VO2 Max and Power Risk ReductionsWhat the hazard ratios actually suggest.44:40 – Elite VO2 Max Targets by Age and SexPractical benchmarks.45:30 – Strength Targets: Leg Press, Chest Press, Grip StrengthWhat the limited data suggests.49:00 – Power Benchmarks: Vertical Jump and Aging50:10 – Why Progress Matters More Than Just “Doing Exercise”Dose-response data on strength and VO2 improvements.52:30 – The Barbell Medicine Longevity Exercise PrescriptionFrom minimum guidelines to optimal training volumes.55:15 – Protein Restriction and mTOR: The Longevity HypothesisRodent data and mechanistic concerns.59:50 – Human Outcome Data: Total vs Plant ProteinWhat prospective studies actually show.01:03:50 – Age-Dependent Protein Effects?Middle age vs older adults.01:04:15 – Practical Protein RecommendationsWhere BBM currently stands.01:08:04 – Are GLP-1s Just Weight Loss Drugs?Reframing incretin therapies01:12:06 – The Muscle Loss ControversyLean mass vs skeletal muscle vs function.01:18:20 – STEP 1 and the 40% Lean Mass ClaimContext and measurement limitations.01:27:30 – Functional Outcomes: SEMA-LEAN DataStrength, sarcopenia risk, and muscle quality.01:31:50 – Beyond Weight Loss: SELECT Trial Cardiovascular Data20% reduction in major adverse cardiac events.01:24:40 – FLOW Trial: Kidney ProtectionRenal outcomes in high-risk patients.01:23:20 – Retatrutide and Multi-Receptor Incretins (TRIUMPH-4)01:31:50 – Alzheimer’s Disease and the EVOKE TrialsManaging expectations for neurodegenerative disease.01:41:00 – HRT and the Women’s Health Initiative ReanalysisAge-stratified cardiovascular risk.01:49:55 – Testosterone Deficiency in MenObesity, TRT, and cardiovascular outcomes.The Barbell Medicine Vital Five01:50:57 – Introducing the Vital Five FrameworkA practical longevity model.01:56:00 – Blood Pressure: The Foundational Metric01:58:00 – ApoB and Atherogenic Risk01:59:45 – VO2 Max as a Clinical KPI02:00:55 – Relative Strength and Function02:02:30 – Body Roundness Index and Body CompositionReferences:Biological Clockhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8853656/ https://pmc.ncbi.nlm.nih.gov/articles/PMC12038942/https://pmc.ncbi.nlm.nih.gov/articles/PMC11424583/  https://pmc.ncbi.nlm.nih.gov/articles/PMC6366976/ Cancer Screeninghttps://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.5574 https://www.thelancet.com/article/S1470-2045(23)00277-2/fulltext https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01700-2/fulltext https://www.nhs-galleri.org/ Exercisehttps://bjsm.bmj.com/content/56/13/755 https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2807854 https://pubmed.ncbi.nlm.nih.gov/35442242/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915309/?mc_cid=87bfcaaa3a&mc_eid=8786146256 https://pmc.ncbi.nlm.nih.gov/articles/PMC9012529/ https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428 https://pubmed.ncbi.nlm.nih.gov/35228201/https://pubmed.ncbi.nlm.nih.gov/35662329/  ​​https://academic.oup.com/biomedgerontology/article/77/4/781/6354429 https://www.sciencedirect.com/science/article/abs/pii/S0025619625001004 https://pmc.ncbi.nlm.nih.gov/articles/PMC12131147/  https://pubmed.ncbi.nlm.nih.gov/18595904/https://pubmed.ncbi.nlm.nih.gov/12242311/ Proteinhttps://pubmed.ncbi.nlm.nih.gov/40418846/ https://pmc.ncbi.nlm.nih.gov/articles/PMC7250948/ https://pubmed.ncbi.nlm.nih.gov/39110456/ https://pubmed.ncbi.nlm.nih.gov/24606898/https://www.bmj.com/content/370/bmj.m2412 GLP-1https://www.cell.com/cell-metabolism/abstract/S1550-4131(26)00008-2 https://www.nejm.org/doi/full/10.1056/NEJMoa2307563 https://www.nejm.org/doi/abs/10.1056/NEJMoa2403347 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltext https://link.springer.com/article/10.1007/s11154-025-09991-4 https://pmc.ncbi.nlm.nih.gov/articles/PMC12338914/HRThttps://pubmed.ncbi.nlm.nih.gov/25754617/ https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00211-6/abstract https://www.nejm.org/doi/full/10.1056/NEJMoa2215025 https://pmc.ncbi.nlm.nih.gov/articles/PMC4527564/ https://www.mdpi.com/1422-0067/25/22/12221 Body Roundness Index (BRI) : https://www.barbellmedicine.com/blog/should-bri-replace-bmi/Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBM* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

How-To Fix Your Stalled Progress (Strength Edition)

Lifting more weight doesn't always mean you've gotten stronger. In this foundational session, Dr. Jordan Feigenbaum and Dr. Austin Baraki introduce the Fitness-Fatigue Model to explain why "stalled" progress is often just a temporary masking of strength by accumulated fatigue. By learning to differentiate between a lack of fitness adaptation and a lack of recovery, you can avoid the "panic pivot" and maintain the long-term signal necessary for elite-level gains.Supercast Sign-UpFor the 6-part audio series and Training Plateau Action Plan, sign-up for Barbell Medicine Plus:https://barbellmedicine.supercast.com/Key Learning PointsThe Fitness-Fatigue Model: Understand the physiological duality of every workout—while a session builds your "fitness" (potential), it also creates "fatigue" that temporarily suppresses your performance.Strength vs. Effort: Performance must be measured relative to RPE. If the weight on the bar increases but the RPE climbs disproportionately (e.g., jumping from RPE 8 to RPE 10 for a 5lb gain), your absolute strength has not actually improved.Noise vs. Signal: A one-week stall is statistical "noise." Constant program hopping in response to a single bad session destroys the cumulative stimulus (the "signal") required for actual tissue adaptation.The Root Cause Audit: Determining the "Why" behind a plateau.Lack of Fitness: The stimulus is no longer sufficient to drive a new adaptation (Needs more volume/intensity).Lack of Recovery: The fatigue is overwhelming the adaptation (Needs a deload or volume reduction).Autoregulation as a Diagnostic Tool: Using RPE not just to prescribe load, but to "interrogate" your current state of recovery and readiness.Timestamps[00:00] Intro: Introducing the Barbell Medicine Plus Exclusive Series[02:15] The Thought Experiment: 310x6 @ 8 vs. 315x6 @ 10[05:30] Deep Dive: Defining the Fitness-Fatigue Model[09:45] Interpreting the Stall: Is it a Stimulus Problem or a Recovery Problem?[14:20] The Danger of "Short-Termism": Why Panicking Destroys the Signal[18:50] Introduction to the 6-Part Audio Course & Actionable PDFPearlsThe Pivot Rule: Never change a successful program based on a single week of data. Look for a 3-week trend of stagnant or declining performance (at the same RPE) before initiating a program pivot.Peaking Mechanics: Most "peaking" protocols do not build new strength; they simply reduce fatigue to reveal the strength you've already built.The stimulus-Recovery Trap: If you feel "beat up" but the weights are moving well, you likely don't need a deload yet. If you feel "great" but the weights are stuck, you likely need a stronger stimulus.Our Sponsors:* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com* Check out Factor: https://factormeals.com/bbm50off* Check out Quince: https://quince.com/BBM* Check out Quince: https://quince.com/BBMSupport this podcast at — https://redcircle.com/barbell-medicine-podcast/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Episode #385- Why Grip Strength Predicts Death (And Why You Shouldn't Train It)

Can a simple one-second squeeze predict your risk of cardiovascular disease, cognitive decline, and all-cause mortality? Dr. Jordan Feigenbaum and Dr. Austin Baraki explore why grip strength has become the go-to metric for the longevity industry and why most people are interpreting the data incorrectly.Timestamps:[00:00] Intro: The Longevity Industry’s Thermometer Error[01:42] The Neuro-Axis: Anatomy of a Maximal Squeeze[06:43] The 35-3-5 Rule: Biomechanics of Grip[09:12] Asymmetries and Clinical Red Flags[17:31] Dynapenia vs. Sarcopenia: Why the Hand Fails First[18:41] Normative Data and the PURE Study Statistics[27:16] Genetics, Lean Body Mass, and Predictive Power[31:44] Absolute vs. Relative Grip Strength (The Metabolic Signal)[37:03] Bro-Science Beatdown: Neural Jitter and Training Readiness[42:19] The Extensor Training and "Grip Maxing" Myth[45:13] Programming: Systemic Training vs. Indirect Grip Work[48:10] The Straps Debate: Are You Killing Your Gains?[52:03] Final Verdict: Hierarchy and Health PrioritiesKey Takeaways:Grip is Systemic: Handgrip strength tests the integrity of the entire system, from the motor cortex in the brain down to the tendons and bones. It is a proxy for overall muscular quality and neurological health.Predictive Power: According to the PURE study, for every 5 kg decrease in grip strength, there is a 17% increased risk of cardiovascular death and a 7% increased risk of non-cardiovascular death.The Sarcopenia Floor: Clinical "red zones" for probable sarcopenia are